Neidio i'r cynnwys

5-hydroxytryptamine receptor 1A

Ni chefnogir cynnwys y dudalen mewn ieithoedd eraill.
Creu erthygl

This is an automatic view based on data from Wicidata.
There is not a complete article yet, but you can help creating one.

mammalian protein found in Homo sapiens

Adnoddau allanol

dynodwr Freebase
/m/03cx8d7
dynodwr Microsoft Academic
2781093953
2910224462
RefSeq protein ID
NP_000515[1]
Transporter Classification Database ID
9.A.14.3.14[2][3]
Guide to Pharmacology Target ID
1[4]
OpenAlex ID
C2781093953[5]
Ensembl protein ID
ENSP00000316244[6]
ENSP00000423433[7]
UniProt protein ID
P08908[8]

enghraifft o'r canlynol

protein[8]

rhan o'r canlynol

5-Hydroxytryptamine 1A receptor[9]
GPCR, rhodopsin-like, 7TM, protein family[10]

found in taxon

Homo sapiens[8]

amgodiwyd gan

HTR1A[8]

swyddogaeth moleciwlaidd

G protein-coupled receptor activity[11][12]

dull penderfynu: IEA

signal transducer activity[13]

dull penderfynu: IEA

G protein-coupled serotonin receptor activity[14][15][12][16][17]

dull penderfynu: IDA, IEA, IMP, TAS

protein binding[18][19]

dull penderfynu: IPI

serotonin binding[20]

dull penderfynu: IBA

neurotransmitter receptor activity[20]

dull penderfynu: IBA

receptor-receptor interaction[21]

dull penderfynu: IDA

G protein-coupled receptor activity[22][23][20]

dull penderfynu: IBA, IEA

G protein-coupled serotonin receptor activity[24][25][23][26][27][20]

dull penderfynu: IBA, IDA, IEA, IMP, TAS

rhan o'r gell

integral component of membrane[22][23]

dull penderfynu: IEA

bilen[22]

dull penderfynu: IEA

Cellbilen[28][22]

dull penderfynu: TAS, IEA

integral component of plasma membrane[29][12][30]

dull penderfynu: IDA, IEA, TAS

integral component of plasma membrane[31][23][32][20]

dull penderfynu: IBA, IDA, IEA, TAS

dendrite[20]

dull penderfynu: IBA

proses fiolegol

G protein-coupled receptor signaling pathway[28][33][25][22][23]

dull penderfynu: IEA, IMP, TAS

regulation of behavior[23]

dull penderfynu: IEA

fasogyfyngiad[23]

dull penderfynu: IEA

adenylate cyclase-inhibiting serotonin receptor signaling pathway[17]

dull penderfynu: IDA

serotonin metabolic process[34][26]

dull penderfynu: ISS, IEA

behavioral fear response[34][26]

dull penderfynu: ISS, IEA

regulation of dopamine metabolic process[34][26]

dull penderfynu: ISS, IEA

regulation of serotonin secretion[34][26]

dull penderfynu: ISS, IEA

exploration behavior[34][26]

dull penderfynu: ISS, IEA

serotonin receptor signaling pathway[34][26]

dull penderfynu: ISS, IEA

positive regulation of cell population proliferation[33]

dull penderfynu: TAS

regulation of hormone secretion[23]

dull penderfynu: IEA

cell population proliferation[23]

dull penderfynu: IEA

signal transduction[22]

dull penderfynu: IEA

animal behaviour[22]

dull penderfynu: IEA

G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger[20]

dull penderfynu: IBA

adenylate cyclase-inhibiting serotonin receptor signaling pathway[27][20]

dull penderfynu: IBA, IDA

chemical synaptic transmission[20]

dull penderfynu: IBA

adweithia'n ffisegol gyda

flibanserin[35]

defnydd: agonist

frovatriptan[36]

defnydd: agonist

LP-12[37]

defnydd: agonist

LP-211[38]

defnydd: agonist

LP-44[39]

defnydd: agonist

1-naphthylpiperazine[40]

defnydd: agonist

5-carboxamidotryptamine[41]

defnydd: agonist

serotonin[42]

defnydd: agonist

(+/-)-8-hydroxy-2-(di-N-propylamino)tetralin[43][44]

defnydd: agonist

aripiprasol[45]

defnydd: agonist

bmy-14802[46]

defnydd: agonist

cabergolin[47]

defnydd: agonist

closapin[48]

defnydd: agonist

CP 93129[49]

defnydd: agonist

donitriptan[50]

defnydd: agonist

eletriptan[51]

defnydd: agonist

EMDT[52]

defnydd: agonist

flesinoxan[53]

defnydd: agonist

lisuride[54]

defnydd: agonist

LSD[55]

defnydd: agonist

LY293284[56]

defnydd: agonist

LY334370[57]

defnydd: agonist

nafadotride[58]

defnydd: agonist

naratriptan[59]

defnydd: agonist

f-15599[60]

defnydd: agonist

ocaperidone[61]

defnydd: agonist

Olanzapine[62]

defnydd: agonist

cwetiapin[63]

defnydd: agonist

quinpirole[64]

defnydd: agonist

rizatriptan[65]

defnydd: agonist

ru-24969[66]

defnydd: agonist

S-14506[67]

defnydd: agonist

S-14671[68]

defnydd: agonist

spiroxatrine[69]

defnydd: agonist

sumatriptan[70]

defnydd: agonist

tandospirone[71]

defnydd: agonist

U92016A[72]

defnydd: agonist

xanomeline[73]

defnydd: agonist

zalospirone[74]

defnydd: agonist

zolmitriptan[75]

defnydd: agonist

apomorphine[76]

defnydd: agonist

BMY-7378[77]

defnydd: agonist

brl-15572[78]

defnydd: agonist

bromocriptin[79]

defnydd: agonist

bwspiron[80]

defnydd: agonist

fluparoxan[81]

defnydd: agonist

gr-127935[82]

defnydd: agonist

ipsapirone[83]

defnydd: agonist

pergolid[84]

defnydd: agonist

piribedil[85]

defnydd: agonist

roxindole[86]

defnydd: agonist

S-15535[87][88]

defnydd: agonist

sb-216641[89]

defnydd: agonist

terguride[90]

defnydd: agonist

vilazodone[91]

defnydd: agonist

vortioxetine[92]

defnydd: agonist

siprasidon[93]

defnydd: agonist

(+)-butaclamol[94]

defnydd: antagonist

clorpromasin[95]

defnydd: antagonist

cyamemazine[96]

defnydd: antagonist

fluspirilene[97]

defnydd: antagonist

haloperidol[98]

defnydd: antagonist

iloperidone[99]

defnydd: antagonist

apiose[100]

defnydd: antagonist

ketanserin[101]

defnydd: antagonist

mesoridasin[102]

defnydd: antagonist

metitepine[103]

defnydd: antagonist

NAN 190[104]

defnydd: antagonist

pimosid[105]

defnydd: antagonist

pindolol[106]

defnydd: antagonist

pipamperone[107]

defnydd: antagonist

pizotyline[108]

defnydd: antagonist

raclopride[109]

defnydd: antagonist

repinotan[110]

defnydd: antagonist

risperidon[111]

defnydd: antagonist

ritanserin[112]

defnydd: antagonist

robalzotan[113]

defnydd: antagonist

sertindole[114]

defnydd: antagonist

spiperone[115]

defnydd: antagonist

thioridasin[116]

defnydd: antagonist

tiospirone[117]

defnydd: antagonist

WAY-100135[118]

defnydd: antagonist

WAY-100635[119]

defnydd: antagonist

yohimbin[120]

defnydd: antagonist

zotepine[121]

defnydd: antagonist

xaliproden[122]

swyddogaeth y gwrthrych: agonist

zimeldine[123]

swyddogaeth y gwrthrych: antagonist

aripiprazole lauroxil[124]

swyddogaeth y gwrthrych: Partial agonist

gepirone[125]

swyddogaeth y gwrthrych: agonist

buspirone hydrochloride[126]

swyddogaeth y gwrthrych: Partial agonist

yn cynnwys

GPCR, rhodopsin-like, 7TM[9]

categori Comin

5-HT1A serotonin receptor

prif gategori

Category:5-HT1A serotonin receptor

Cyfeiriadau

  1. ↑ NCBI Gene, 30 Mai 2020, 3350
  2. ↑ Transporter Classification database, 13 Mawrth 2020
  3. ↑ Transporter Classification database, 29 Ebrill 2020
  4. ↑ https://www.wikidata.org/w/index.php?title=Wikidata:Property_proposal/Guide_to_Pharmacology_Target_ID&oldid=709819452
  5. ↑ OpenAlex, 26 Ionawr 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  6. ↑ Ensembl Release 99, ENSP00000316244
  7. ↑ Ensembl Release 99, ENSP00000423433
  8. ↑ 8.0 8.1 8.2 8.3 UniProt, 13 Tachwedd 2019, P08908
  9. ↑ 9.0 9.1 InterPro Release 71.0, http://www.ebi.ac.uk/interpro/protein/P08908
  10. ↑ inferred from protein domain or family
  11. ↑ IEA, 16 Gorffennaf 2018, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  12. ↑ 12.0 12.1 12.2 IEA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16 Gorffennaf 2018, InterPro, GOA
  13. ↑ IEA, 1 Ionawr 2018, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  14. ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16 Gorffennaf 2018, Proteome Inc., Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity, GOA
  15. ↑ IMP, 16 Gorffennaf 2018, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  16. ↑ IEA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16 Gorffennaf 2018, Ensembl, GOA
  17. ↑ 17.0 17.1 IDA, 16 Gorffennaf 2018, P08908, Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  18. ↑ IPI, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Parkinsons Disease Gene Ontology Initiative, Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2, GOA
  19. ↑ IPI, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, IntAct protein interaction database, Fibroblast growth factor receptor 1- 5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity, GOA
  20. ↑ 20.0 20.1 20.2 20.3 20.4 20.5 20.6 20.7 20.8 IBA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, GO Central, Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium, GOA
  21. ↑ IDA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Parkinsons Disease Gene Ontology Initiative, Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2, GOA
  22. ↑ 22.0 22.1 22.2 22.3 22.4 22.5 22.6 IEA, 8 Ebrill 2019, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  23. ↑ 23.0 23.1 23.2 23.3 23.4 23.5 23.6 23.7 23.8 IEA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, InterPro, GOA
  24. ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Proteome Inc., Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity, GOA
  25. ↑ 25.0 25.1 IMP, 8 Ebrill 2019, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  26. ↑ 26.0 26.1 26.2 26.3 26.4 26.5 26.6 IEA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Ensembl, GOA
  27. ↑ 27.0 27.1 IDA, 8 Ebrill 2019, P08908, Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  28. ↑ 28.0 28.1 TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Reactome, GOA
  29. ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, 16 Gorffennaf 2018, Proteome Inc., The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor, GOA
  30. ↑ IDA, 16 Gorffennaf 2018, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?protein=P08908&geneProductId=UniProtKB:P08908, UniProt
  31. ↑ TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Proteome Inc., The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor, GOA
  32. ↑ IDA, 8 Ebrill 2019, P08908, Role of glycosphingolipids in the function of human serotonin₁A receptors, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  33. ↑ 33.0 33.1 TAS, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, 8 Ebrill 2019, Proteome Inc., Activation of 5-HT1A receptors expressed in NIH-3T3 cells induces focus formation and potentiates EGF effect on DNA synthesis, GOA
  34. ↑ 34.0 34.1 34.2 34.3 34.4 34.5 ISS, 8 Ebrill 2019, P08908, GOA, http://www.ebi.ac.uk/QuickGO/annotations?geneProductId=UniProtKB:P08908, UniProt
  35. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8182, Saesneg
  36. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7191, Saesneg
  37. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8434, Saesneg
  38. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8436, Saesneg
  39. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8435, Saesneg
  40. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 3, Saesneg
  41. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 4, Saesneg
  42. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 5, Saesneg
  43. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7, Saesneg
  44. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 31, Saesneg
  45. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 34, Saesneg
  46. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 8, Saesneg
  47. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 37, Saesneg
  48. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 38, Saesneg
  49. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 11, Saesneg
  50. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 39, Saesneg
  51. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 40, Saesneg
  52. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 12, Saesneg
  53. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 1, Saesneg
  54. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 43, Saesneg
  55. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 17, Saesneg
  56. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 19, Saesneg
  57. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 20, Saesneg
  58. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 44, Saesneg
  59. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 45, Saesneg
  60. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 3924, Saesneg
  61. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 46, Saesneg
  62. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 47, Saesneg
  63. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 50, Saesneg
  64. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 2, Saesneg
  65. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 51, Saesneg
  66. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 23, Saesneg
  67. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 24, Saesneg
  68. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 25, Saesneg
  69. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 53, Saesneg
  70. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 54, Saesneg
  71. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 55, Saesneg
  72. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 30, Saesneg
  73. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 57, Saesneg
  74. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 58, Saesneg
  75. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 60, Saesneg
  76. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 33, Saesneg
  77. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 9, Saesneg
  78. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 10, Saesneg
  79. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 35, Saesneg
  80. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 36, Saesneg
  81. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 41, Saesneg
  82. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 14, Saesneg
  83. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 42, Saesneg
  84. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 48, Saesneg
  85. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 49, Saesneg
  86. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 52, Saesneg
  87. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 26, Saesneg
  88. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 32, Saesneg
  89. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 28, Saesneg
  90. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 56, Saesneg
  91. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7427, Saesneg
  92. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7351, Saesneg
  93. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 59, Saesneg
  94. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 62, Saesneg
  95. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 83, Saesneg
  96. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 84, Saesneg
  97. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 85, Saesneg
  98. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 86, Saesneg
  99. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 87, Saesneg
  100. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 68, Saesneg
  101. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 88, Saesneg
  102. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 7227, Saesneg
  103. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 89, Saesneg
  104. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 73, Saesneg
  105. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 90, Saesneg
  106. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 91, Saesneg
  107. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 92, Saesneg
  108. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 93, Saesneg
  109. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 94, Saesneg
  110. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 95, Saesneg
  111. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 96, Saesneg
  112. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 97, Saesneg
  113. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 72, Saesneg
  114. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 98, Saesneg
  115. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 99, Saesneg
  116. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 100, Saesneg
  117. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 101, Saesneg
  118. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 79, Saesneg
  119. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 80, Saesneg
  120. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 102, Saesneg
  121. ↑ IUPHAR/BPS Guide to PHARMACOLOGY, 17 Awst 2016, 103, Saesneg
  122. ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL1512580
  123. ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL37744
  124. ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL2219425
  125. ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL284092
  126. ↑ Open Targets Platform, 14 Awst 2023, https://platform.opentargets.org/drug/CHEMBL1200399
Wedi dod o "https://cy.wikipedia.org/wiki/Arbennig:Am_y_Pwnc/Q21115043"